PMEF
TWST icon

Point72 Middle East FZE’s Twist Bioscience TWST Stock Holding History

Point72 Middle East FZE’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,541
Closed -$112K – 1891
2023
Q3 		$112K Buy
+5,541
New +$122K ﹤0.01% 1125
2023
Q2 		– Sell
-8,311
Closed -$125K – 2068
2023
Q1 		$125K Buy
8,311
+7,642
+1,142% +$169K ﹤0.01% 1058
2022
Q4 		$15.9K Buy
+669
New +$19.4K ﹤0.01% 1677

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Middle East FZE's TWST Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Twist Bioscience (TWST) in Q4 2023, closing a stake of 5,541 shares — an estimated $112K sold.

Point72 Middle East FZE first reported a position in TWST in Q4 2022 and held it in 3 quarters. The position peaked at $125K in Q1 2023. 218 funds tracked by Wall St. Rank hold TWST as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Twist Bioscience position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 5,541 Twist Bioscience shares in Q4 2023, an estimated $112K.
  • Point72 Middle East FZE first reported a position in Twist Bioscience in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Twist Bioscience position peaked at $125K in Q1 2023.
  • 218 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.